Objectives To compare expulsions and adverse events (AEs) between immediate and delayed insertion of a levonorgestrelreleasing intrauterine system (LNG-IUS) following medical termination of pregnancy (MTOP).
Introduction
Long-acting reversible contraception (LARC), by means of intrauterine devices (IUDs) and systems or contraceptive implants, is the most effective medical method to prevent unwanted pregnancy. [1] [2] [3] The introduction of medical termination of pregnancy (MTOP) has rapidly changed the practice of induced termination of pregnancy (TOP). The proportion of MTOPs is increasing in several countries: in 2015 its use exceeded 55% in England and Wales, and was up to 81% in Scotland, 91% in Sweden, and 96% in Finland. [4] [5] [6] [7] The safety and effectiveness of IUD insertion immediately after the surgical termination of pregnancy is well documented. [8] [9] [10] [11] After MTOP, IUD insertion typically takes place within a few weeks. Even if women are highly motivated to start intrauterine contraception at the time of TOP, up to half of them do not return for further visits and therefore miss access to effective contraception. 12, 13 We have recently shown that when IUD insertion is provided cost-free as part of the TOP service by the same clinic providing MTOP, the insertion rate was up to 91%.
14 Results concerning IUD insertion within 1-3 weeks after early MTOP (<9 weeks of gestation) are promising; expulsion rates were indistinguishable when compared with later insertions, and no major complications have been reported. 13, 15, 16 No data are yet available concerning the initiation of intrauterine contraception after MTOP performed at later durations of gestation, however. As late TOP is an independent risk factor for subsequent TOP, actions to minimise the risk of subsequent TOP are crucial. 17 To minimise additional visits and maximise the rate of initiation of intrauterine contraception after MTOP we performed a randomised controlled trial in which we compared immediate (same day) and delayed (2-4 weeks) insertion of a levonorgestrel-containing intrauterine system (LNG-IUS). This was performed in two subgroups of women requesting TOP: during late first or second trimester. The main outcome measures were LNG-IUS expulsion rates, early adverse events, and bleeding profiles.
Methods
In this prospective randomised trial we compared the immediate (same day) and delayed (2-4 weeks after misoprostol) insertion of LNG-IUS (Mirena â , purchased from Bayer, Turku, Finland) after MTOP. The trial was conducted at the Department of Obstetrics and Gynaecology, Helsinki University Hospital, Finland.
At the time of MTOP the participants were randomised in a 1:1 allocation ratio to immediate or delayed LNG-IUS insertion by using a computer-generated list. Block randomisation with block sizes of four and six was carried out, and sequentially numbered opaque envelopes were used. The personnel responsible for generating the randomisation list and sealing the envelopes did not take part in enrolment.
Adult women (aged ≥ 18 years) requesting MTOP and planning to use LNG-IUS for post-TOP contraception were recruited between 30 January 2013 and 31 December 2014. We had two gestational-age subgroups: late first trimester (64-84 days of gestation) and second trimester (85-140 days of gestation). Recruitment to the second-trimester group was halted after the inclusion of 57 patients because of slow enrolment. Women with contraindications for LNG-IUS (uterine abnormality, submucosal fibroid, suspected uterine or cervical neoplasia, or acute pelvic infection) were not recruited to the study. Written informed consent was obtained before enrolment. Before the medical procedure, women were screened for Chlamydia trachomatis infection and treated if they tested positive. The women received mifepristone (Mifepristone Linepharma â , Linepharma, France), 200 mg orally, and misoprostol (Cytotec â ; Pfizer, Sandwich, Kent, UK), 400 lg 24-72 hours later vaginally at the hospital (orally in cases of heavy bleeding) every 3 hours until fetal expulsion.
In women randomised to the immediate-insertion group the LNG-IUS was inserted before the women were discharged from hospital. If the woman was randomised to the immediate-insertion group and surgical evacuation of the uterus was needed according to clinical judgment at the time of TOP, the LNG-IUS insertion occurred during the procedure.
The first follow-up visit was 2-4 weeks after MTOP. At this visit the LNG-IUS location was confirmed by ultrasonography. Among the women randomised to delayed insertion, the LNG-IUS insertion occurred at this time. Fundal endometrial thickness was measured in both groups by ultrasonography. If surgical evacuation of retained products of conception was needed, according to symptoms and clinical judgement, LNG-IUS insertion was carried out during the procedure. The three investigators (all with >10 years of experience in LNG-IUS insertion) performed all of the insertions. A follow-up visit was scheduled at 3 months after insertion.
The women recorded their uterine bleeding during a 90-day reference period after MTOP by using a bleeding chart. A three-point scale of heavy bleeding, bleeding, and spotting was used to grade the bleeding. Heavy bleeding was described as a need for the largest sanitary towels during the day, or overflow at night, bleeding was described as the need for a normal sanitary towel or tampon, and spotting was described as the need for a panty liner or small tampon, or no need of sanitary protection.
The second follow-up visit was 3 months after LNG-IUS insertion. During this visit the study nurse checked for the presence and appropriate thread length of the LNG-IUS. If threads were not visible or appeared too long, the researcher performed ultrasonography. The third follow-up was at 1 year, at which time the researcher performed a clinical examination and ultrasonography. Possible complications were recorded at every follow-up visit. If the patient did not attend the follow-up visit, the research nurse tried to contact her by calling or text-messaging two or three times, and if contacted, a new appointment was scheduled if desired. To minimise the drop-out rate and maximise the information gained, the comprehensive electronic patient files of the hospital district were revised.
The primary outcome was the LNG-IUS expulsion rate. The LNG-IUS was recorded as being 'expelled' when spontaneously and completely expelled from the uterus, and 'partially expelled' if any part of the LNG-IUS was visible in the cervix, or if the LNG-IUS stem was seen in the cervix upon ultrasonography. A new LNG-IUS was offered at no charge if it was partially or totally expelled. Secondary outcomes were the rate of clinically diagnosed pelvic infection, the need of surgical operations, bleeding problems necessitating some extra contact at the clinic or any procedure (vacuum aspiration, hysteroscopy, medication, blood transfusion), bleeding patterns, and uterine perforation.
The sample size calculation was based on the reported expulsion rate (including both total and partial expulsions) of 8% following post-TOP insertion. 8, 13, 15 In order to show that expulsion rates are equivalent, we considered a relative difference of ≤20% to be clinically insignificant. Assuming an alpha level of 0.05 for a two-sided Student's t-test, 48 subjects per group would result in 90% power. A loss to follow-up of 4% was anticipated; we planned to recruit 50 patients per group. As we wanted to assess the expulsion rate at different gestational ages, we aimed to recruit 100 women to each subgroup.
Categorical data were analysed by cross-tabulation, and statistical significance was calculated using Fisher's exact test. The Mann-Whitney U-test was used for continuous variables. The analysis of bleeding diaries was modified from the method described by Belsey et al. 18 The numbers of bleeding and spotting days, length of first bleeding episode, and numbers of bleeding and/or spotting episodes were calculated. At least 2 days of no bleeding or spotting were required between episodes. All analyses were performed using SPSS v22 and SPSS v24 (IBM Corp., Armonk, NY, USA). Figure 1 shows the flow chart concerning the study participants and Table S1 shows the women attending follow-ups according to their gestational age subgroups. A total of 159 women were randomised: 102 in late first trimester and 57 in second trimester. One woman requesting a second-trimester MTOP in the immediate-insertion group continued her pregnancy and two women had suspected cervical neoplasia according to Pap-smear test (one women during late first trimester and one during second trimester), and they were not included in the intention-to-treat analysis. Table 1 shows the demographics of the study participants. Randomisation did not result in any statistically significant differences between the study groups.
Results
In the late first trimester, 50 (98.0%) women in the immediate-insertion group and 41 (82.0%) women in the delayed-insertion group received LNG-IUS insertion (risk ratio, RR 1.20; 95% confidence interval, 95% CI 1.04-1.37; P = 0.008). The corresponding figures in the second trimester were 26 (96.3%) versus 23 (82.1%) (RR 1.17, 95% CI 0.97-1.41, P = 0.19), respectively.
The LNG-IUS insertion was also analysed by per-protocol basis (only after an uncomplicated MTOP and in a predefined time frame). In late first trimester, 43 (84.3%) versus 35 (70.0%) women in the immediateversus delayed-insertion group (RR 1.20, 95% CI 0.97-1.50, P = 0.10) received LNG-IUS insertion per protocol. In the second trimester, these figures were 25 (92.6%) versus 22 (78.6%) women (RR 1.18, 95% CI 0.94-1.47, P = 0.25), respectively. The times between misoprostol treatment and LNG-IUS insertion, sound measurements, and endometrial thickness differed between the immediate and delayed insertion groups, but no significant differences occurred in insertion pain scores or insertion problems (Table S2 ).
In the per-protocol population the median (interquartile range) time from the first misoprostol dose to the follow-up visit at 2-4 weeks was 19 (16) (17) (18) (19) (20) (21) 
Primary outcome
The LNG-IUS expulsion rates according to gestational-age subgroups are presented in Table 2 . By 3 months the overall expulsion rate in the late first-trimester group was 14 (27.5%) in the immediate-insertion group versus two (4.0%) in the delayed-insertion group (RR 6.86, 95% CI 1.64-28.66, P = 0.002). The majority of these were partial expulsions [12 (23.5%) versus 1 (2.0%)]. Few additional partial expulsions were detected after 3 months, resulting in 1-year expulsion rates of 17 (33.3%) versus six (12%) (RR 2.78, 95% CI 1.19-6.47, P = 0.017). In the second-trimester group all expulsions were partial and occurred within 3 months [5 (18.5%) versus 1 (3.6%), RR 5.19, 95% CI 0.65-41.54, P = 0.10].
Two out of three total expulsions diagnosed were symptomatic: one patient noticed the expulsion herself before the first follow-up at 2-4 weeks (in the immediate-insertion group), and one woman contacted the hospital because of bleeding problems approximately 2 months after LNG-IUS insertion (in the delayed-insertion group). Only one unnoticed total expulsion was diagnosed at the 3-month follow-up visit (in the immediate-insertion group).
Partial expulsions in the late first-trimester group were noted in the immediate-insertion group in the first follow-up at 2-4 weeks (seven cases), between follow-ups (two cases), at the 3-month follow-up (three cases), between the 3-month and 1-year follow-ups (one case), and at the 1-year follow-up (two cases). In the delayed-insertion group one partial expulsion was noted 1 week after insertion and an additional four were diagnosed at the 1-year follow-up. In the second-trimester group partial expulsions following immediate LNG-IUS insertion were diagnosed before the first follow-up (one case), in the follow-up at 2-4 weeks (three cases), and at the 3-month follow-up (one case). In the delayed-insertion group the only partial expulsion case was detected at the 3-month follow-up. Half of the partial expulsions [13 (50%)] were diagnosed by ultrasonography only.
Secondary outcomes
No cases of uterine perforation occurred during the LNG-IUS insertions. Table 3 shows the rate of adverse events following MTOP. Surgical evacuation of the uterus was performed within 4 days following the beginning of misoprostol administration in seven cases in the immediateinsertion group (one case of failed MTOP, three retained placentas, and three cases of heavy bleeding), and in eight cases in the delayed-insertion group (two cases of failed MTOP, two retained placentas, and four cases of heavy Data are presented as median (interquartile range) or n (%).
bleeding). A later (>4 days after TOP) surgical procedure was performed in four cases (one case of retained products of conception with bleeding and three cases of infection) versus six cases (three cases of retained products of conception with bleeding and three cases with infection). Retained products of conception were treated by means of misoprostol administration in five cases in the delayed-insertion group. Almost all infections diagnosed were considered to be mild cervicitis or endometritis (uterine tenderness and/or purulent discharge as symptoms), and were treated with oral antibiotics. One woman in the delayed-insertion group received intravenous antibiotics and underwent vacuum aspiration 20 days after TOP, before LNG-IUS insertion. In the immediate-insertion group two LNG-IUSs were cervically located and removed at the time of infection diagnosis, and only two LNG-IUSs were removed because of infection. In the delayed-insertion group all infections were diagnosed before LNG-IUS insertion, 2-4 weeks after TOP.
The completed bleeding diaries were returned by 44 (56.4%) women who received the LNG-IUS per protocol in the immediate-insertion group and by 31 (39.7%) women in the delayed-insertion group (RR 1.42, 95% CI 1.01-1.99, P = 0.054). Bleeding patterns are presented in Table S3 and the bleeding profiles are shown in Figure S1 . No differences emerged in the overall numbers of bleeding days between the study groups during the 90-day reference period. To assess the validity of the returned diaries, the women who returned them were compared with those who did not return completed diaries with regards to demographic background factors. Both groups were similar: only the non-smokers (return rates 59.2% versus 38.8%, RR 1.52, 95% CI 1.10-2.12, P = 0.016) were over-represented in the group who returned their diaries. Insertion problems and pain scores did not affect the return rates.
Discussion

Main findings
Our results show that immediate LNG-IUS insertion following MTOP is feasible. The overall expulsion rate within 3 months was higher following immediate LNG-IUS insertion compared with delayed insertion (27.5% versus 4.0%). The increased partial expulsion rate in the immediate group explained the difference between the groups (23.5% versus 2.0%). The complication rates or bleeding profiles did not differ significantly between the study groups. We had no serious adverse events, such as uterine perforation, related to LNG-IUS insertion. Importantly, immediate LNG-IUS insertion did not increase the risk of retained products of conception.
Strengths and limitations
A strength of our study is its randomised design. In addition, immediate LNG-IUS insertion following late first-trimester or second-trimester MTOP has not been studied before. Concerning shortcomings of the study, the dropout rates were higher than presumed in the sample-size calculation; however, the patients were advised to contact our research nurse or the emergency department if experiencing problems concerning the TOP or the LNG-IUS. Complications associated with TOP are mostly treated at public hospitals in Finland, and our hospital is in charge of termination of pregnancy care in the Helsinki metropolitan area. Hence, the patients' clinical records would have revealed all serious TOP-related complications. Limited conclusions should be made when considering the results of the second-trimester subgroup because it did not recruit enough women for statistical significance. Also, the expulsion rates were higher than expected at the time of performing the power analysis, thus the study is likely to be underpowered.
Interpretation
After first-trimester surgical TOP, expulsion rates of immediately inserted IUDs have been reported as 3.4% within 6 months, 19 and 0.8-7.1% within 12 months. 8, [20] [21] [22] The lowest expulsion rates, however, are derived from retrospective register data or phone calls, and may underestimate the values. Immediate IUD insertion at the time of second-trimester dilatation and evacuation has been associated with expulsion rates of 3.0-3.1%. 22 Our total LNG-IUS expulsion rates (4.7% in the late first-trimester subgroup and 0% in the second-trimester subgroup) following immediate insertion are comparable with these figures. The partial expulsion rates were higher (25.6% in the late first-trimester subgroup and 20.0% in the second-trimester subgroup) than those published earlier, however. It is worth noting that routine ultrasonography might have led to an overestimation of partial expulsions, as half of the diagnoses were based on that, not on clinical symptoms. Moreover, previous studies on the intracervical use of LNG-IUS have also shown that cervically located LNG-IUS is as effective a contraceptive as fundally located LNG-IUS. 23 Thus, partial expulsions may not have such significant clinical importance.
The rate of clinically diagnosed infections in the two gestational age groups was relatively high: 9.8% and 22.2% in the immediate-insertion group versus 8.0% and 17.9% in the delayed-insertion group. In Finnish registerbased studies the infection rate after first-trimester MTOP has been reported to be 1.4%, and it increased to 4.0% when the TOP took place in the second trimester. 24, 25 In our previous randomised trial the infection rates after first-trimester MTOP were 5.7% (control group) and 9.4% (intervention group) during the 3-month follow-up period; 14 however, most of the women in these studies had undergone an early TOP (<9 weeks of gestation). In a randomised trial comparing one-and two-day dosing intervals between mifepristone and misoprostol in secondtrimester TOP, the rates of clinically diagnosed infections were 11.3% and 8.9%, respectively. 26 The similar infection rates seen in our study groups suggest that the infections were related to MTOP itself and not to the immediate LNG-IUS provision. It should be noted that as part of the clinical trial the women had easy access to consultation and treatment, which might have led to some overdiagnosis.
The bleeding patterns during the 90-day reference period were indistinguishable following immediate and delayed LNG-IUS insertion. Thus, importantly, immediate LNG-IUS insertion does not seem to increase the duration or volume of post-TOP bleeding.
The participants of this study differed slightly from the average of women requesting TOP in Finland:
7 the study population was older (median age 25-28 years) compared with average (20-24 years), and more often had a history of previous TOP (48-57% compared with 37%). This may reflect the inclusion criteria of this study: adult women wishing for the most effective reversible contraception. These demographic factors were similar between the study groups, however, suggesting little effect on the outcomes (expulsions or complications). In Finland, as in the UK, TOP is most often requested among women in the age group of 20-24 years. 4, 5, 7 The second largest age group is 25-29 years, however, and the annual TOP rates in this age group have remained at same level or even slightly increased both in Finland and in the UK. Moreover, among this older age group nearly half have a history of previous TOP in England and Wales. 4 Thus, it is likely that this study population represents a group of women who are at increased risk for another unplanned pregnancy, and so promoting long-acting contraception is especially important for them.
Conclusion
We conclude that immediate LNG-IUS insertion after MTOP performed during the late first trimester or second trimester is feasible and safe, and is therefore an important option to ease access to and ensure the uptake of long-acting contraception; however, immediate insertion resulted in a higher overall LNG-IUS expulsion risk. This might limit its cost-effectiveness, and should be considered in the patient information and planning of the follow-up visits.
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